Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

VYNE Therapeutics (VYNE) Cash from Investing Activities (2017 - 2025)

VYNE Therapeutics' Cash from Investing Activities history spans 9 years, with the latest figure at $4.7 million for Q2 2025.

  • For Q2 2025, Cash from Investing Activities fell 75.42% year-over-year to $4.7 million; the TTM value through Jun 2025 reached $32.4 million, up 169.12%, while the annual FY2025 figure was $37.4 million, 59.93% up from the prior year.
  • Cash from Investing Activities reached $4.7 million in Q2 2025 per VYNE's latest filing, down from $19.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $19.8 million in Q1 2025 to a low of -$62.4 million in Q4 2023.
  • Average Cash from Investing Activities over 5 years is $600916.7, with a median of $2.9 million recorded in 2021.
  • Peak YoY movement for Cash from Investing Activities: tumbled 6235500.0% in 2023, then soared 655.65% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at $1.0 million in 2021, then crashed by 99.9% to $1000.0 in 2022, then crashed by 6235500.0% to -$62.4 million in 2023, then surged by 120.43% to $12.7 million in 2024, then plummeted by 63.3% to $4.7 million in 2025.
  • Per Business Quant, the three most recent readings for VYNE's Cash from Investing Activities are $4.7 million (Q2 2025), $19.8 million (Q1 2025), and $12.7 million (Q4 2024).